[HTML][HTML] Natural history of Barth syndrome: a national cohort study of 22 patients
C Rigaud, AS Lebre, R Touraine, B Beaupain… - Orphanet journal of rare …, 2013 - Springer
Background This study describes the natural history of Barth syndrome (BTHS). Methods
The medical records of all patients with BTHS living in France were identified in multiple …
The medical records of all patients with BTHS living in France were identified in multiple …
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30‐year nationwide cohort of 1478 patients under 18 years of age
C Rigaud, MA Barkaoui, C Thomas… - British journal of …, 2016 - Wiley Online Library
The French national cohort of children with Langerhans cell histiocytosis ( LCH ) has included
1478 patients since it was established in 1983. LCH therapeutic strategies substantially …
1478 patients since it was established in 1983. LCH therapeutic strategies substantially …
Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults
…, L Amoroso, S Buffardi, C Rigaud… - Blood, The Journal …, 2023 - ashpublications.org
Children, adolescents, and young adults (CAYA) with relapsed/refractory (R/R) classic
Hodgkin lymphoma (cHL) without complete metabolic response (CMR) before autologous …
Hodgkin lymphoma (cHL) without complete metabolic response (CMR) before autologous …
Identification of prognostic markers in transthyretin and AL cardiac amyloidosis
Background: The prognosis of amyloidosis is known to depend heavily on cardiac function
and may be improved by identifying patients at highest risk for adverse cardiac events. Aims: …
and may be improved by identifying patients at highest risk for adverse cardiac events. Aims: …
Efficacy of nivolumab in a patient with systemic refractory ALK+ anaplastic large cell lymphoma
C Rigaud, S Abbou, V Minard-Colin… - Pediatric blood & …, 2018 - pubmed.ncbi.nlm.nih.gov
… Charlotte Rigaud …
[HTML][HTML] Differentiated thyroid cancer in children and adolescents: long term outcome and risk factors for persistent disease
…, J Hadoux, I Breuskin, E Baudin, C Rigaud… - Cancers, 2021 - mdpi.com
Simple Summary Despite their excellent prognosis, pediatric differentiated thyroid cancers (P-DTC)
often undergo aggressive treatment due to the advanced disease presentation. …
often undergo aggressive treatment due to the advanced disease presentation. …
Outcome of relapse in children and adolescents with B‐cell non‐Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study
C Rigaud, A Auperin, A Jourdain… - Pediatric Blood & …, 2019 - Wiley Online Library
Introduction In order to describe relapsed B‐cell non‐Hodgkin lymphoma and mature acute
leukemia in children/adolescents treated with the Lymphomes Malins B (LMB) regimen and …
leukemia in children/adolescents treated with the Lymphomes Malins B (LMB) regimen and …
Molecular and clinicopathologic characterization of pediatric histiocytoses
…, JL Stephan, A Leruste, C Rigaud… - American Journal of …, 2023 - Wiley Online Library
The spectrum of somatic mutations in pediatric histiocytoses and their clinical implications
are not fully characterized, especially for non‐Langerhans cell histiocytosis (‐LCH) subtypes. …
are not fully characterized, especially for non‐Langerhans cell histiocytosis (‐LCH) subtypes. …
Pheochromocytoma and paraganglioma in children and adolescents: experience of the French Society of Pediatric Oncology (SFCE)
…, C Pluchart, Y Réguerre, C Rigaud… - Journal of the …, 2020 - academic.oup.com
Purpose The purpose of this work is to assess the clinical outcome of pediatric patients
diagnosed with pheochromocytoma and paraganglioma (PPGL) detected in France since 2000. …
diagnosed with pheochromocytoma and paraganglioma (PPGL) detected in France since 2000. …
Diagnosis and management of ALK-positive anaplastic large cell lymphoma in children and adolescents
C Rigaud, F Knörr, L Brugières… - Best Practice & Research …, 2023 - Elsevier
Anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL) is a
CD30-positive T cell lymphoma characterized by signalling from constitutively activated ALK …
CD30-positive T cell lymphoma characterized by signalling from constitutively activated ALK …
